The Implantable Infusion Pumps Market Size is valued at 15.81 Billion in 2022 and is predicted to reach 23.98 Billion by the year 2031 at a 4.9 % CAGR during the forecast period for 2023-2031.
The global implantable infusion pumps market is segmented on the basis of application and region. Based on the application, the market is divided into malignant pain management, cancer treatment, non-malignant pain management, and spasticity treatment. Based on region, the market is studied across North America, Asia-Pacific, Europe, Latin America and Middle East & Africa. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some of The Key Players in The Implantable Infusion Pumps Market:
- Codman & Shurtleff, Inc (Johnson & Johnson)
- I-Flow Corp/Hylard Health
- Flowobix Medical, Inc.
- Medtronic
- Tricumed Medizintechnik GmbH.
- Debiotech SA
- Eksigent Technologies LLC
- InBrain Pharma SAS
- Intarcia Therapeutics Inc
- Other Prominent Players
The Implantable Infusion Pumps Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2022 |
USD 15.81 Billion |
Revenue Forecast In 2031 |
USD 23.98 Billion |
Growth Rate CAGR |
CAGR of 4.9 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Billion, Volume (Unit), and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Application, By Product Type, By End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Codman & Shurtleff, Inc (Johnson & Johnson), I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., Debiotech SA, Eksigent Technologies LLC, InBrain Pharma SAS, Intarcia Therapeutics Inc., and others |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |